Visible light reprograms MSCs and T cells into tumor-suppressive states via OPN4-mediated epigenetic remodeling.
Cellular metabolism critically influences tumor resistance. These findings demonstrate that visible light pulses can epigenetically reprogram MSCs and T cells, offering a potential therapeutic strategy for breast cancer and bone metastasis.
Cellular metabolism critically influences tumor resistance. These findings demonstrate that visible light pulses can epigenetically reprogram MSCs and T cells, offering a potential therapeutic strategy for breast cancer and bone metastasis.
What the study was
- Study design
- Not specified
- Category
- Treatment Innovation
- Maturity
- Exploratory
- Journal
- Acta pharmacologica Sinica
Why it surfaced
Relevant Novel therapeutics: immunotherapy, CAR-T, targeted therapy study (promising preliminary signal) meets standard-priority threshold.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.